Literature DB >> 1725296

Tissue specificity of the endothelin-induced responses.

T Masaki1.   

Abstract

Endothelin (ET-1) has many activities in various tissues and organs. Even in the vascular system, ET-1 elicits vasodilation as well as vasoconstriction. These diverse responses induced by ET-1 are ascribed to the balance between ET-1 and ET-3 effects that are mediated by (a) at least two types of calcium channel activated by ET, (b) three distinct prototypes of ET-receptor subtypes, (c) the diversity of the intracellular signal transduction system, especially cyclooxygenase products, and (d) modulation of hormonal and neuronal factors.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1725296     DOI： 10.1097/00005344-199100177-00002

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN： 0160-2446            Impact factor:   3.105


  9 in total

1.  Necessity of dual blockade of endothelin ETA and ETB receptor subtypes for antagonism of endothelin-1-induced contraction in human bronchi.

Authors:  T Fukuroda; S Ozaki; M Ihara; K Ishikawa; M Yano; T Miyauchi; S Ishikawa; M Onizuka; K Goto; M Nishikibe
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

2.  Endothelin-1 does not mediate hypoxic vasoconstriction in canine isolated blood vessels: effect of BQ-123.

Authors:  S A Douglas; L M Vickery-Clark; E H Ohlstein
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

3.  Endothelin-3 at low concentrations attenuates inflammatory responses via the endothelin B2 receptor.

Authors:  Akira Sato; Keiichi Ebina
Journal:  Inflamm Res       Date:  2013-01-31       Impact factor: 4.575

4.  Discrimination between ETA- and ETB-receptor-mediated effects of endothelin-1 and [Ala1,3,11,15]endothelin-1 by BQ-123 in the anaesthetized rat.

Authors:  M Bigaud; J T Pelton
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

5.  Modulatory effects of endothelin-1 on purinergic and adrenergic components of sympathetically-mediated contractile activity of rabbit saphenous artery.

Authors:  V N Mutafova-Yambolieva; R G Radomirov
Journal:  Br J Pharmacol       Date:  1994-08       Impact factor: 8.739

6.  Selectivity of [125I]-PD151242 for human, rat and porcine endothelin ETA receptors in the heart.

Authors:  M G Peter; A P Davenport
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

7.  Interaction between endothelin and vasodilators in the human internal mammary artery.

Authors:  G W He; C Q Yang; M J Mack; T E Acuff; W H Ryan; A Starr
Journal:  Br J Clin Pharmacol       Date:  1994-12       Impact factor: 4.335

8.  Involvement of ETA receptors in the facilitation by endothelin-1 of non-adrenergic non-cholinergic transmission in the rat urinary bladder.

Authors:  M V Donoso; C Salas; G Sepúlveda; J Lewin; A Fournier; J P Huidobro-Toro
Journal:  Br J Pharmacol       Date:  1994-02       Impact factor: 8.739

9.  Circulating levels of endothelin-1 (ET-1) and its precursor (Big ET-1) in breast cancer early diagnosis.

Authors:  Vasileios Kalles; George C Zografos; Xeni Provatopoulou; Eleni Kalogera; Paraskevi Liakou; Georgia Georgiou; Alexandros Sagkriotis; Aphroditi Nonni; Antonia Gounaris
Journal:  Tumour Biol       Date:  2012-03-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.